Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
2.470
-0.110 (-4.26%)
Nov 20, 2024, 4:00 PM EST - Market closed
Purple Biotech Employees
Purple Biotech had 20 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
20
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$582,900
Market Cap
5.08M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Check-Cap | 85 |
Kindly MD | 65 |
Sharps Technology | 57 |
Applied DNA Sciences | 55 |
Sunshine Biopharma | 44 |
Predictive Oncology | 35 |
Genprex | 26 |
Silo Pharma | 3 |
PPBT News
- 5 days ago - Purple Biotech Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 16 days ago - Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death - GlobeNewsWire
- 26 days ago - Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK Cell Engagers Antibody Platform, CAPTN-3, at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 5 weeks ago - Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN-3—at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - GlobeNewsWire
- 2 months ago - Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24 - GlobeNewsWire
- 2 months ago - Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Purple Biotech Reports Second Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 4 months ago - Purple Biotech Receives Extension to Regain Compliance with the Nasdaq's Minimum Bid Price Rule - GlobeNewsWire